Matt Wills’ Post

ZS’s Cody Powers and Josh Hattem share data on pharma launches and approvals and why clinical trials continue to decline. Read our first portfolio and business development quarterly report: #pharma #pharmatrends #ZSpharmalaunchreport

ZS’s Cody Powers and Josh Hattem share data on pharma launches and approvals and why clinical trials continue to decline. Read our first portfolio and business development quarterly report: #pharma #pharmatrends #ZSpharmalaunchreport

ZS’s Cody Powers and Josh Hattem share data on pharma launches and approvals and why clinical trials continue to decline. Read our first portfolio and business development quarterly report: #pharma #pharmatrends #ZSpharmalaunchreport

ZS’s Cody Powers and Josh Hattem share data on pharma launches and approvals and why clinical trials continue to decline. Read our first portfolio and business development quarterly report: #pharma #pharmatrends #ZSpharmalaunchreport

ZS’s Cody Powers and Josh Hattem share data on pharma launches and approvals and why clinical trials continue to decline. Read our first portfolio and business development quarterly report: #pharma #pharmatrends #ZSpharmalaunchreport

Struggling to navigate the dynamic pharma industry? Discover our Better Market Access initiative, where you'll find the latest insights, webinars and strategies to tackle the complexities of pharma market access. Learn how to enhance your market entry, manage regulatory challenges, and optimize your market access strategy for success. Explore more here: skp.link/vpy #SimonKucher #Pharma #MarketAccess #BetterMarketAccess

What lies in the pharma industry’s future? 🔮 We asked over 100 industry experts to share their views on the therapeutic areas to watch. Find out their thoughts 👉 https://ow.ly/eFJr50UsmTH #PharmaceuticalInnovation #FutureofPharma

Navigating #Accumulators and alternative funding programs can be challenging, but experts from Pfizer and Exelixis shared valuable insights at the 2024 Hub and Specialty Pharma Model West conference. Their take? #PatientAssistancePrograms (PAP) could be critical in tackling these challenges to ensure patients get the support they need. Download our Hub West recap today to learn more ➡ https://hubs.li/Q032SpGX0 #PatientSupport #PharmaSolutions #CopayAssistance

Join our live panel, on June 11, with biopharma and market access and communication experts from Cencora | Pharma solutions. We will discuss the impact of biosimilars on the U.S. market and identify strategies to navigating regulatory hurdles, fostering collaborations, and enhancing communication with stakeholders amidst dynamic market changes. Register now at: https://lnkd.in/gh7rJmYu #Biosimilars #Marketaccess

How to drive cutting edge omnichannel and two-way communication with HCPs? Watch this insightful video with Emily Warner and Jill Shoffner-Brown from #Boehringer!